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Pentameric ligand-gated ion channels (pLGICs) mediate synaptic transmission and are sensitive to their lipid environment. The mechanism of phospholipid modulation of any pLGIC is not well understood. We demonstrate
that the model pLGIC, ELIC (Erwinia ligand-gated ion channel), is positively
modulated by the anionic phospholipid, phosphatidylglycerol, from the
outer leaﬂet of the membrane. To explore the mechanism of phosphatidylglycerol modulation, we determine a structure of ELIC in an open-channel
conformation. The structure shows a bound phospholipid in an outer leaﬂet
site, and structural changes in the phospholipid binding site unique to the
open-channel. In combination with streamlined alchemical free energy perturbation calculations and functional measurements in asymmetric liposomes, the data support a mechanism by which an anionic phospholipid
stabilizes the activated, open-channel state of a pLGIC by speciﬁc, statedependent binding to this site.

pLGICs such as the nicotinic acetylcholine receptor (nAChRs) are
ubiquitous in the nervous system where they determine synaptic
transmission and neuronal excitability1. These channels are targets of
general anesthetics and anti-epileptics2, and potential targets for the
treatment of many neuropsychiatric diseases3–5. pLGIC function is
modulated by certain lipids6, including anionic phospholipids which

enhance agonist response in the nAChR7–11. Anionic phospholipids, as
well as sterols and fatty acids, have also been shown to modulate other
pLGICs12–16. It is intuitive that lipids modulate pLGICs by inﬂuencing the
conformational stability of different states that the channel samples
during gating; however, mechanisms of phospholipid modulation of
any pLGIC remain poorly understood.
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With the recent abundance of lipid-bound pLGIC structures by
cryo-EM, investigation into the structural mechanisms of lipid modulation has focused on direct binding of lipids to speciﬁc sites12,13,15,17–22.
Structures of the 5-HT3A receptor (5-HT3AR), GABAA receptor, nAchR
and the prototypic pLGICs, Erwinia chrysanthemi ligand-gated ion
channel (ELIC) and Gloeobacter violaceus ligand-gated ion channel
(GLIC), show bound phospholipids at various sites14,19,23–28. However, a
phospholipid density in a structure is insufﬁcient evidence for a
modulatory mechanism6. Establishing such a mechanism demands
knowledge of the functional effect of the phospholipid, identity of
phospholipids that occupy the site, and state-dependent binding at
that site consistent with the modulatory effect of the phospholipid.
Recent structural studies of ELIC show a phospholipid and cardiolipin
density bound to different sites in the apo or resting structure, but
functional analysis indicates that cardiolipin increases the open
probability of the channel14,26. Another study of the 5-HT3AR shows
evidence of state-dependent phospholipid binding, but the identity of
this phospholipid in the structure and the modulatory effect of
phospholipids in 5-HT3AR is unknown23.
In this study, we determine a structural mechanism for anionic
phospholipid positive modulation of the pLGIC, ELIC. An open-channel
structure of ELIC shows a phospholipid density in an outer leaﬂet
intersubunit site not well resolved in non-conducting structures. The
phospholipid binding site shows a distinct conformation in the openchannel structure. Along with streamlined free energy perturbation
calculations29 and functional measurements in asymmetric proteoliposomes the results support a mechanism by which the anionic
phospholipid, phosphatidylglycerol (PG), stabilizes the activated,
open-channel state of ELIC by binding to a speciﬁc site.

Results
Modulation of ELIC by neutral and anionic phospholipids
pLGICs such as the nAchR require an anionic phospholipid and phosphatidylethanolamine (PE) for maximal agonist response7. Using a
ﬂuorescence stopped-ﬂow liposomal ﬂux assay, we previously showed
that ELIC agonist responses are signiﬁcantly enhanced in 2:1:1 POPC
(1-palmitoyl-2-oleoyl-phosphatidylcholine): POPE (1-palmitoyl-2-oleoylphosphatidylethanolamine): POPG (1-palmitoyl-2-oleoyl-phosphatidylglycerol) liposomes compared to POPC-only liposomes13,30. This
effect manifested as an increase in peak response, and decrease in the
rate and extent of desensitization (Fig. 1a, b). However, the exact contributions of POPG and POPE on these effects were not clear.
To delineate the respective effects of these lipids, ELIC activity was
measured in binary mixtures of 3:1 or 1:1 of POPC:POPE or POPC:POPG.
Responses were measured using 10 mM propylamine (a saturating
concentration of agonist, Supplementary Fig. 1a), since cysteamine (the
agonist used previously13) at concentrations >5 mM is incompatible with
the permeating ion, thallium (Tl+). Only POPG (25–50 mol% POPG) slowed desensitization (Fig. 1c, d). Accordingly, POPG increased relative
channel activity at 10 and 25 s after agonist application (Supplementary
Fig. 2). This ﬁnding is consistent with patch-clamp experiments showing
that POPG decreases the extent of desensitization in ELIC13,26. Interestingly, both POPG and POPE were required to achieve maximal responses
(Fig. 1d), indicating that both lipids are needed to facilitate channel
activation. However, the EC50 for the peak agonist dose-response in
POPC-only liposomes was not signiﬁcantly different than in 2:1:1
POPC:POPE:POPG liposomes (Supplementary Fig. 1). Taken together,
the results indicate that POPG modulates ELIC by stabilizing the activated, open-channel state relative to desensitized states13,26. In the presence of POPE, POPG also enhances channel peak response, which may
result from an increase in gating efﬁcacy or an effect on desensitization.
While differences in channel reconstitution and orientation in the various liposome compositions could also contribute to the effect on peak
response, experiments using asymmetric liposomes described below
control for these factors, verifying that POPG increases peak channel
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activity. Furthermore, no signiﬁcant difference was appreciated in the
size of POPC and 2:1:1 POPC:POPE:POPG liposomes used for the assay
(Supplementary Fig. 3).

Capturing an open-channel conformation of ELIC
To investigate the mechanism of positive modulation by POPG, we
determined structures of WT ELIC by single particle cryo-electron
microscopy (cryo-EM) in the absence and presence of agonist in
MSP1E3D1 nanodiscs with 2:1:1 POPC:POPE:POPG (hereafter referred to
as 2:1:1) or POPC (Supplementary Fig. 4, Supplementary Table 1). For all
structures, 10 mM cysteamine was used as the agonist since this is a
saturating concentration of the most potent, known agonist of ELIC
(Supplementary Fig. 6b)31. The POPC and 2:1:1 WT ELIC apo structures
were indistinguishable. Likewise, the agonist-bound structures were
identical in both lipid conditions (Supplementary Fig. 5), deviating
insigniﬁcantly from apo and propylamine-bound structures in POPC
nanodiscs previously reported14,32. Importantly, the agonist-bound
structures showed a non-conducting pore with occlusion at 16’ (F247)
and 9’ (L240) (Fig. 2e, f). Thus, structures of WT ELIC in poorly activating POPC compared to activating 2:1:1 lipids exhibited no meaningful structural differences.
Since POPG stabilizes the activated, open-channel state of ELIC,
we aimed to capture an open-channel conformation using gain-offunction mutations. We began with the previously reported gain-offunction triple mutant V261Y/G319F/I320F (ELIC3)33 that introduces
three aromatic residues at the top of the M4 helix (M4) (Supplementary Fig. 6a). As previously reported, ELIC3 caused a left-shift in the
agonist dose response curve, slowed desensitization in the presence of
agonist, and slowed deactivation as assessed by excised patch-clamp
recordings from 2:1:1 giant liposomes (Supplementary Fig. 6b–e).
Interestingly, the structure of agonist-bound ELIC3 in 2:1:1 nanodiscs,
determined at 3.3 Å resolution (Supplementary Fig. 4, Supplementary
Table 1), showed opening of the pore at 16′ but still occlusion at 9′
(Fig. 2d–f). Seeking a mutant that remains open in the presence of
agonist, we added the mutations P254G (previously shown to slow
deactivation34) and C300S (previously shown to slow desensitization
in the presence of agonist12,35), and produced P254G/C300S/V261Y/
G319F/I320F (ELIC5) (Supplementary Fig. 6a). Strikingly, ELIC5 showed
a deactivation rate ~1000× slower than WT and no evidence of
desensitization in the presence of 10 mM cysteamine (Fig. 2a, Supplementary Fig. 6e), indicative of profound stabilization of the activated, open-channel state. In four recordings of ELIC5 currents in
response to 10 mM cysteamine where single channel openings were
resolved, there was no evidence of channel closure for several minutes
(Supplementary Fig. 6g), suggesting that ELIC5 has a high open
probability at steady state. Consistent with its gain-of-function phenotype, a structure of ELIC5 in 2:1:1 nanodiscs with 10 mM cysteamine,
determined at 3.4 Å resolution (Supplementary Figs. 4 and 7, Supplementary Table 1), yielded an apparent open pore (Fig. 2d–f) with a
pronounced outer leaﬂet phospholipid-shaped density (Fig. 2c).
The structures of WT, ELIC3 and ELIC5 reveal different pore
conformations that indicate a possible sequence of changes from a
resting to open-channel conformation (Fig. 2d, e). The WT apo structure shows constrictions at 16′ and 9′ (Fig. 2e), consistent with resting
pore conformations reported for the nAchR19,28,36. In the presence of
agonist, the top of M2 in WT shows a modest blooming of 16′. The
ELIC3 gain-of-function mutant further opens at 16′ with the F247 side
chain turning away from the pore into an intersubunit space, but
otherwise resembles the WT structure. Finally, in ELIC5, 9′ rotates away
from the pore into an intersubunit space and 16′ opens further, such
that the narrowest diameter of the pore is at 2′ (Q233) (Fig. 2f). Two
rotameric states of Q233 could be modeled in the structure yielding a
minimum pore diameter of 5.6 Å (rotamer 1, ELIC5 CA 1) and 7.3 Å
(rotamer 2, ELIC5 CA 2) (Fig. 2f and Supplementary Fig. 8). The larger
pore diameter is consistent with the capacity of ELIC to conduct large
2
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Fig. 1 | ELIC agonist responses in different lipid conditions. a Left: Schematic of
the sequential mixing experiment for the ﬂuorescence liposomal stopped-ﬂow
assay (created with BioRender.com). ELIC proteoliposomes containing the ﬂuorescent Tl+ indicator, ANTS, are mixed with agonist (propylamine), and then with Tl+
solution after a variable delay time. Right: Representative raw ﬂuorescence traces;
the ﬁrst 0.1 s are ﬁt with a stretched exponential to determine the ﬂuorescence
quenching rate, which relates to ELIC channel activity. The legend shows control
(no agonist) and different delay times. b Tl+ ﬂux rates of WT ELIC in 2:1:1 POPC:POPE:POPG (black) and POPC (red) liposomes as a function of time after mixing
with 10 mM propylamine (n = 3). Inset shows activation time course of normalized
data. Activation was too fast to accurately determine the rate. c Normalized Tl+ ﬂux

rates of WT ELIC in POPC, 3:1 POPC:POPG and 1:1 POPC:POPG as a function of time
after mixing with 10 mM propylamine (n = 3). d Weighted time constant for the time
course of desensitization in response to 10 mM propylamine from the Tl+ ﬂux assay
for the indicated liposome compositions (n = 3). 2:1:1 indicates 2:1:1 POPC:POPE:POPG. e Same as c showing peak channel activity (rate) in response to 10 mM
propylamine from the Tl+ ﬂux assay (2:1:1, n = 12; other, n = 3). Statistical analysis
was performed using a one-way ANOVA and post-hoc Tukey test. ** indicates
p < 0.01 when comparing 2:1:1 with all other liposome compositions. P-values for
these comparisons with 2:1:1 are 0.003 for POPC, 0.006 for 3:1 PC:PE, 0.005 for 1:1
PC:PE, 0.002 for 3:1 PC:PG and 0.003 for 1:1 PC:PG. Data are shown as mean ± se for
(n) independent experiments. Source data are provided as a source data ﬁle.

quaternary cations37. ELIC5 has the same single channel conductance
as WT (Fig. 2b, Supplementary Fig. 6f); this along with its high open
probability strongly suggests that the ELIC5 structure represents a
functionally-relevant open-channel conformation. The fact that the
pore diameters at 16′ (12.6 Å) and 9′ (13 Å) in the ELIC5 CA structure are
much larger than at 2′ is consistent with previous ﬁndings that mutations of 9′ and 16′ do not affect ion conduction37. Further work will be
necessary to assess the contribution of Q233 rotameric states to ion
conductance and selectivity38–40.
The patch-clamp and Tl+ ﬂux data of WT and ELIC3 show robust
activation and desensitization in 2:1:1 membranes such that agonistbound structures of WT and ELIC3 are expected to show desensitized
conformations. However, the observed structures are most consistent
with pre-active conformations based on structures of other pLGICs,
especially the nAchR, where 16′ and 9′ appear to be activation gates
and desensitization consistently involves a constriction in the most

intracellular aspect of the pore28,32,35,36. It is possible that some
unknown factor inﬂuencing the cryo-EM structures is producing this
apparent discrepancy or that these structures actually represent
desensitized conformations in ELIC. Therefore, we cannot conﬁdently
assign the WT and ELIC3 agonist-bound structures as pre-active or
desensitized conformations, and further work is necessary to clarify
their annotation. Hereafter, to examine POPG modulation of ELIC, we
will focus on WT apo, WT agonist-bound (WT CA) and the ELIC5
agonist-bound (ELIC5 CA) structures all in 2:1:1 nanodiscs, which are
putative resting, agonist-bound non-conducting and open-channel
conformations, respectively.
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ELIC channel opening is associated with an outer leaﬂet bound
phospholipid
The ELIC5 CA structure shows a strong phospholipid density at an
outer leaﬂet site within an intersubunit groove formed by M4, M3 and
3
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Fig. 2 | Conformational changes of pore opening. a Representative ELIC currents
in response to 10 mM cysteamine of excised patches from 2:1:1 POPC:POPE:POPG
giant liposomes (black = WT, red = ELIC5, −60 mV holding voltage). The ELIC5
currents show sustained response to 10 mM cysteamine, followed by slow deactivation with the removal of cysteamine. b Inset that shows ELIC5 (red) single channel
currents taken from the deactivation trace (i.e., channel closure) or WT (black)
single channel currents in the presence of 10 mM cysteamine. c Cryo-EM density
map of ELIC5 in 2:1:1 POPC:POPE:POPG nanodiscs + 10 mM cysteamine (grey) with
outer leaﬂet lipid density (yellow) and black lines approximating the bilayer. d View

of the pore lining M2 helix from the extracellular side showing 16’ (F247) and 9′
(L240) side chains from WT apo, WT CA (WT + 10 mM cysteamine), ELIC3 CA
(ELIC3 + 10 mM cysteamine), and ELIC5 CA (ELIC5 + 10 mM cysteamine). All are
structures in 2:1:1 POPC:POPE:POPG nanodiscs. e Ion permeation pathway as
determined by HOLE76 of the same structures shown in d. The ELIC5 CA structure
shows rotamer 2 for Q233 (see Supplementary Fig. 8 for a comparison of rotamers 1
and 2). Labeled are 16′, 9′, and 2′ side chains which form the narrowest portions of
the pore in different structures. f Pore radius as a function of distance along the
pore axis for the same structures as d and e.

M1 (Fig. 3a). The density has well-resolved features including nearly full
density for the palmitoyl-oleoyl acyl chains. Of the six structures
obtained in this study, three others show evidence of phospholipid
density at this outer leaﬂet site, including WT apo structures in POPC
and 2:1:1, and the WT agonist-bound structure in 2:1:1 (Supplementary
Fig. 9a)14. Thus, among agonist-bound structures, phospholipid density at this site was not observed in POPC nanodiscs. To compare the
strength of the phospholipid densities in 2:1:1 structures, we low pass

ﬁltered the maps to 3.5 Å resolution and displayed the map for each
lipid at a sigma value of 3.0 (Fig. 3b). The maps show relatively weak
lipid density in the WT CA structure compared to the ELIC5 CA
structure, suggesting higher occupancy of a phospholipid in the openchannel conformation relative to the agonist-bound non-conducting
conformation at this site.
The phospholipid binds at an outer leaﬂet site with the headgroup
located below the β6-β7 loop and adjacent to the M2-M3 linker, and
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the diacylglycerol in an intersubunit groove formed by M4, M3 and M1
(Fig. 3a). Importantly, the mutated residues in ELIC5 are not located
directly in the lipid binding site (Supplementary Fig. 6a and below).
Closer examination of this site shows major conformational changes
between the WT apo, WT CA and ELIC5 CA structures (Supplementary
Movies 1 and 2). The β6-β7 loop progressively translates outward from
WT apo to WT CA to ELIC5 CA (Fig. 3c), placing the basic residue, R117,
less than 4 Å from the phospholipid headgroup in the ELIC5 CA
structure (Fig. 3a, Supplementary Fig. 9b). Movement of the β6-β7 loop
is associated with an outward translation of the M2-M3 linker and the
top of M3 and M1, which is largest in the ELIC5 CA structure (Fig. 3c).
The outward translation of these structures is linked to a global outward blooming of 4–5 Å of all four transmembrane helices leading to
opening of the pore (Fig. 3d, Supplementary Movies 3 and 4). Thus,
conformational changes in the phospholipid binding site of the openchannel structure of ELIC, especially in the β6-β7 loop where R117
interacts with the phospholipid headgroup, reveals a plausible
mechanism for stabilization of the open-channel conformation by an
anionic phospholipid such as POPG.
Activation of ELIC is also associated with movement of a semiconserved aromatic residue, W206 in M1, which is implicated in
binding of zwitterionic phospholipids41 and located in this outer leaﬂet
phospholipid binding site (Fig. 3c). Indeed, we observed phospholipid
density directly interacting with W206 in the WT apo structures in
POPC and 2:1:1 nanodiscs (Fig. 3b, Supplementary Fig. 9b). However,
while W206 faces into the bilayer in the resting structure, in agonistbound structures (WT CA and ELIC5 CA), it ﬂips into an intersubunit
space displacing M3 and the M2-M3 linker and dramatically changing
the structure of this lipid binding site (Fig. 3c, Supplementary Fig. 9b).
We discovered that the tryptophan ﬂuorescence of ELIC decreases
with the addition of agonist, and that this decrease is entirely attributed to W206 (no change in ﬂuorescence is observed in W206F with
and without agonist, Supplementary Fig. 10a, b). Taking advantage of
this unique agonist-dependent signal, we monitored tryptophan
ﬂuorescence of ELIC after rapid mixing of propylamine, to compare
the rate of W206 movement with channel opening from the thallium
ﬂux assay. Although this measurement was performed with ELIC in
DDM, the rate of decrease in tryptophan ﬂuorescence was approximately 2–4× faster than channel opening in 2:1:1 or POPC liposomes
from the thallium ﬂux assay (Supplementary Fig. 10c). This ﬁnding
indicates that W206 moves away from the protein-lipid interface
during activation. W206 has been reported to form cation-pi interactions with phospholipids in the resting conformation favoring zwitterionic over anionic phospholipids42; however, movement of W206
away from the membrane with channel activation may alter the speciﬁcity of this site for phospholipids such as PG.
The WT apo, WT CA and ELIC5 CA structures show other notable
differences in the ECD and TMD associated with channel activation and
opening of the pore. In the ECD, agonist binding initiates movement of
loop C towards the pore vestibule clamping down on the agonist
(Supplementary Fig. 11a), a conformational change previously described in ELIC and other pLGICs32. However, in the ELIC5 CA structure, the
agonist binding site remains clamped down but translates away from
the pore (Supplementary Fig. 11a). Associated with this translation,
there is a general expansion of the ECD β-sheets β1-β6 (Supplementary
Fig. 5a, Supplementary Movies 5–8). In the TMD, the outward blooming of the TM helices in the ELIC5 CA structure extends to the bottom
of the transmembrane helices (Supplementary Fig. 11b), and is associated with an outward translation of 4.7 Å and straightening of M4
below P305, a conserved proline that produces a kink in the M4 helix in
non-conducting structures of ELIC (Supplementary Fig. 11c)26. Interestingly, the cryo-EM density for M4 is weaker in the WT structures
with an absence of density beyond I317, in contrast to ELIC5 CA, which
showed a relatively stronger M4 density (Supplementary Figs. 7, 9 and
11c). Thus, ELIC opening is associated with an outward movement and
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straightening of M4, while non-conducting structures show evidence
of a more dynamic M4 consistent with previous reports of M4 in the
desensitized state26.
In summary, the ELIC5 CA structure shows key conformational
changes associated with channel opening, and a putative mechanism
by which a phospholipid stabilizes the open-channel conformation of
ELIC through an outer leaﬂet binding site.

POPG modulates ELIC from the outer leaﬂet
To further assess the possibility that POPG modulates ELIC from
this binding site in the outer leaﬂet, we measured ELIC function in
asymmetric liposomes using the ﬂuorescence stopped-ﬂow ﬂux
assay13,30,43–46. ELIC was reconstituted in 3:1 POPC:POPE liposomes, after
which the sample was split and treated with methyl-β-cyclodextrin
alone (no-exchange), or methyl-β-cyclodextrin with POPG (exchange)
set to introduce 25 mole% POPG to the outer leaﬂet (Fig. 4a)44. The
presence of outer leaﬂet POPG was assessed by zeta potential
measurements44. The asymmetric proteoliposomes had a similar zeta
potential as symmetric 2:1:1 POPC:POPE:POPG liposomes, indicating
successful introduction of 25 mol% POPG in the outer leaﬂet and no
signiﬁcant ﬂipping of POPG to the inner leaﬂet (Fig. 4b)44,47. Moreover,
the zeta potentials of asymmetric liposomes with 25 mol% outer leaﬂet
POPG with and without ELIC were identical, indicating that ELIC does
not cause ﬂipping of POPG from the outer to inner leaﬂet or, itself, alter
the zeta potential (Fig. 4b).
The addition of methyl-β-cyclodextrin alone did not alter ELIC
responses (Supplementary Fig. 12). However, introduction of 25 mol%
POPG to the outer leaﬂet increased the peak agonist response
approximately two-fold and reduced the rate of desensitization
(Fig. 4c–e). This effect recapitulates the effect of POPG in symmetric
liposomes (Fig. 1). Of note, the reconstitution efﬁciency and orientation of ELIC in the no-exchange and exchange liposomes are the same,
since both samples are taken from the same batch of proteoliposomes.
Thus, in the asymmetric liposome experiments, peak responses
between no-exchange and exchange samples can be attributed to
channel activity. Overall, these data show that POPG modulates ELIC
from the outer leaﬂet, increasing peak channel activity and decreasing
channel desensitization. Not having examined the effect of POPG in the
inner leaﬂet alone, we cannot exclude the possibility that POPG can
also modulate ELIC from the inner leaﬂet as has been previously
proposed13,26.

POPG binds speciﬁcally to the outer leaﬂet site in
the open-channel structure
Having established that POPG modulates ELIC gating from the outer
leaﬂet, we further assessed whether this effect is mediated by the
phospholipid bound to the outer leaﬂet site. We hypothesized that this
site is speciﬁc for POPG and that POPG binding favors the openchannel over non-conducting conformations. To test this, we carried
out streamlined alchemical free energy perturbation (SAFEP29) simulations to determine the relative afﬁnities of POPC, POPE, and POPG for
binding modes corresponding to the phospholipid-shaped density in
WT CA and ELIC5 CA structures. Representative density of POPG
bound to the ELIC5 CA structure is shown in Fig. 5a. Using SAFEP, we
determined the relative probabilities of POPG, POPC, or POPE for the
outer leaﬂet site, conditional upon the requirement that the glycerol
backbone for each phospholipid remains within 6 Å of the reference
conﬁguration, which is the upper limit observed in simulations of the
bound state (Supplementary Fig. 13). These calculations revealed
preferential binding of POPG for the outer leaﬂet site in a 2:1:1
POPC:POPE:POPG membrane for both WT CA and ELIC5 CA structures
(Table 1).
To investigate state dependence and the effect of membrane
composition, we extrapolated to a range of ternary compositions to
obtain phospholipid binding curves (Fig. 5b). In a 2POPC:1POPE:xPOPG
6

Article

https://doi.org/10.1038/s41467-022-34813-5

SO3

-

No Exchange

O3S

SO3

-

7
0

0.1

PG
PC

NH2 SO3

-

βCD

Exchange

O3S

-

SO3

-

Fluorescence (V)

Tl+

PE

8

Time Constant
of Desensitization (s)

Ex
No Ex

100
80
60
40
20

0.05
Time (s)

8
6
4
2

30

-50

0.1

p = 0.01

120
100
80
60
40
20

0
10
20
Delay Time (s)

-40

e

0
0

-30

-60

p = 0.03

10

-20

7

Peak Rates (s-1)

d

c

Control
500ms
10s

7.5

0

Rates (s-1)

0.05
Time (s)

-10

3:1 PC:PE Ex

O 3S

2:1:1

-

0
7.5

Zeta Potential (mV)

NH2 SO3

-

b

3:1 PC:PE Ex ELIC

-

NH2 SO3

8

3:1 PC:PE

Fluorescence (V)

Tl+

a

0
No Ex

Ex

No Ex

Ex

Fig. 4 | Asymmetric liposome stopped-ﬂow Tl+ ﬂux assay. a Schematic representation of asymmetric liposome stopped-ﬂow Tl+ ﬂux assay (created with BioRender.com). Starting with 3:1 POPC:POPE liposomes reconstituted with ELIC, the
sample was either treated with mβCD (top, “No Exchange”), or treated with mβCD/
POPG to introduce 25 mole% POPG to the outer leaﬂet (bottom, “Exchange”). Right:
Representative ﬂuorescence quenching traces for no exchange (top) and exchange
(bottom) samples showing control (no agonist) and responses to 10 mM propylamine with 500 ms and 10 s delay times. b Zeta potential measurements of symmetric 3:1 POPC:POPE liposomes (3:1 PC:PE) (n = 3), symmetric 2:1:1
POPC:POPE:POPG liposomes (2:1:1) (n = 3), asymmetric 3:1 POPC:POPE liposomes
treated to introduce 25 mol% POPG to the outer leaﬂet (3:1 PC:PE Ex) (n = 2), and
asymmetric 3:1 POPC:POPE proteoliposomes with ELIC treated to introduce 25 mol

% POPG to the outer leaﬂet (3:1 PC:PE Ex ELIC) (n = 4). c Tl+ ﬂux rates of WT ELIC in
3:1 PC:PE no exchange liposomes (red, “No Ex”) and exchanged asymmetric liposomes where 25 mol% POPG is introduced to the outer leaﬂet (black, “Ex”) (n = 4).
Channel activation was elicited by 10 mM propylamine. d Weighted time constant
of desensitization in the presence of 10 mM propylamine from Tl+ ﬂux assay
comparing no exchange and exchange conditions (n = 4). Statistical analysis was
performed using a paired, two-sided T-test. e Peak rate of Tl+ ﬂux in response to
10 mM propylamine in no exchange and exchange conditions (n = 4). Statistical
analysis was performed using a paired, two-sided T-test. All data are shown as
mean ± s.e. for (n) independent experiments. Source data are provided as a
source data ﬁle.

ternary mixture, POPC rarely occupies the outer leaﬂet site, while POPE
occupies the site at very low xPOPG. At higher xPOPG, POPG displaces
POPE from the site, indicating preferential binding of POPG for the
outer leaﬂet site. We deﬁne the x50 as the mole fraction of POPG
required to achieve 50% occupancy. From the curves in Fig. 5b, we
estimate that x50 ~ 10−5 and x50 ~ 10−2 for the ELIC5 and WT conformations, respectively, which is consistent with POPG stabilization of
the ELIC5 CA conformation in these ternary mixtures. Estimated relative stabilities of ELIC5 CA and WT CA are shown for a continuum of
ternary compositions in Fig. 5c. Relative to pure POPC, where the
relative stabilization is 0 by deﬁnition, adding POPE stabilizes the nonconducting WT CA conformation, and adding POPG stabilizes the
open-channel ELIC5 CA conformation.
Since the lipid binding site differs between apo and agonist-bound
structures especially due to movement of W206 (Supplementary
Fig. 9b), we examined POPG binding to this site in the WT apo structure. Equilibrium MD simulations of POPG in the binding mode
observed in the WT apo structure showed unbinding of the POPG
headgroup after about 10 ns of simulation time, consistent with previous simulations in apo ELIC structures (Supplementary Fig. 14)42.
Thus, POPG occupancy of the outer leaﬂet site is higher in agonistbound structures particularly the ELIC5 CA structure.

T259A and W206F) (Fig. 6a)14. The mutations were tested as for WT by
examining the effect of 25 mol% outer leaﬂet POPG in paired (no
exchange versus exchange) samples (Supplementary Fig. 15). Three
mutations (Q264L, R117A, and T259A) showed an apparent loss-offunction in that agonist responses were low (T259A) or undetectable
(Q264L and R117A); to improve the signal, we increased the amount of
protein 10× for the reconstitution of these mutants. Despite the
mutations having various effects on ELIC agonist responses, comparison of no exchange and exchange samples enabled assessment of the
effect of POPG.
The mutations can be categorized into those where both effects of
POPG (increased peak response and decreased desensitization) are
abolished (R117A, S202A), those where POPG modulation is preserved
(Q264L), and those where POPG only decreases desensitization
(R318A, T259A, W206F) (Fig. 6b–d). R117A, which mutates a basic
residue near the phospholipid headgroup in the open-channel structure (Fig. 6a), strikingly ablates both measures of POPG modulation
(Fig. 6c, d). S202A at the top of M1 also produced a loss of POPG
modulation. Q264L activation and desensitization was very fast such
that maximum activity was seen at the shortest time point (i.e., 10 ms
delay time), making the exact peak response and rate of desensitization uncertain. Nevertheless, Q264L showed a 2× increase in the
measurable peak response with POPG (Fig. 6d) and signiﬁcantly higher
activity at delay times of 2.5 to 10 s with POPG (Fig. 6b), indicating that
POPG positively modulates peak response and desensitization in this
mutant. Consistent with this ﬁnding, Q264 is > 7 Å removed from the
phospholipid headgroup in the WT CA and ELIC5 CA structures (Fig. 6a

Functional role of the outer leaﬂet POPG binding site
We next tested the effect of mutations that directly interact with the
phospholipid in the ELIC5 CA structure (R117, T259), or are near this
site and previously shown to interact with cardiolipin (S202, R318A,
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Fig. 5 | Predicted lipid occupancy for the outer leaﬂet phospholipid binding
site. a ELIC5 CA structure showing lipid density from a brief 20 ns equilibrium MD
simulation to estimate expected thermal ﬂuctuations of the glycerol backbone
around the structurally-modeled POPG (pink licorice). The region of glycerol
backbone density is shown in black, while the remaining lipid density is shown in
pink. The ﬁve mutations of ELIC5 are shown in black licorice. b The SAFEPcalculated probability (pocc) that the structurally-identiﬁed site will be occupied by
each of three possible lipids in a 2POPC:1POPE:xPOPG mixture, for both the WT CA

and Supplementary Fig. 9b). R318A, T259A and W206F abolished the
effect of POPG on peak response, but still showed an effect of POPG on
desensitization, with some variability (Fig. 6b–d). The reason for this
discrepancy, especially T259A which showed a profound slowing of
desensitization with POPG, is unclear (Fig. 6c). While the mutations
have complex effects on channel function and POPG modulation, the
apparent loss of POPG modulation in R117A, which disrupts a charged
interaction with the POPG headgroup, and the loss of POPG effect on
peak response in multiple mutations implicates the outer leaﬂet
intersubunit site in the mechanism of POPG modulation.

Discussion
It has been known for four decades that anionic phospholipids are
critical for maximal agonist response in the nAChR8,9. More recently,
anionic phospholipids have been shown to modulate ELIC13,14. Many
structures of different pLGICs including ELIC show bound
phospholipids19,23–25, intimating that phospholipid modulation is
mediated by direct binding to speciﬁc site(s). By capturing an openchannel conformation of ELIC, the results of this study suggest a
mechanism for POPG modulation of ELIC through an outer leaﬂet
intersubunit site. While the presence of a stronger phospholipid density in the open-channel structure relative to non-conducting

Table 1 | Free energy differences calculated from SAFEP
Local
Environment
Transformation of
Bulk Lipid

Transformation of
Bound Lipid

POPE to
POPC
(kcal/mol)

POPE to
POPG
(kcal/mol)

1±1

−17 ± 2

3POPC:1POPG

−1 ± 1

−21 ± 3

POPC

−1 ± 1

−17 ± 1

WT CA

5±1

−19 ± 2

ELIC5 CA

3±1

−24 ± 2

2POPC:1POPE: 1POPG
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conformation (top) and the ELIC5 CAconformation
(bottom). c The predicted

p

ELIC5 as a function of mole fraction of
WT
POPG and POPE in a POPG:POPE:POPC mixture. Red and blue correspond to greater
stability of the WT CA and ELIC5 CA conformations, respectively. White arrows
indicate compositions where bulk calculations were carried out; remaining values
were extrapolated as described in Methods. Data in panels b and c represent over
3 μs of simulation; pharmacological models relied on SAFEP-calculated parameters
as described in Methods.
relative conformational stability Δlog

p

structures does not exclude the possibility of POPG interaction at this
site in non-conducting conformations, it does suggest higher occupancy of POPG in the open-channel conformation, which was substantiated by the FEP calculations. One caveat to this interpretation is
the possibility that the ELIC5 mutations promote interaction of POPG
at this site. While we cannot rule out this possibility, it seems less likely
since the mutated residues do not make direct contact with the
phospholipid. A recent structure of ELIC in SMA nanodiscs showed
cardiolipin bound to an overlapping outer leaﬂet site14. Like POPG,
cardiolipin also positively modulates ELIC. Another study using MD
simulations showed that zwitterionic lipids such as PC selectively bind
to this site forming a cation-pi interaction with W20641. However, both
studies examined resting state structures where W206 faces into the
bilayer. In our agonist-bound structures including the open-channel
structure, W206 has turned into an intersubunit space, drastically
changing the structure of this lipid binding site and making PG occupancy more favorable. Therefore, it seems plausible that cardiolipin
occupancy of this site may also differ in open-channel relative to nonconducting conformations14. Interestingly, a recent study demonstrated that the polyunsaturated fatty acid, docosahexaenoic acid
(DHA), inhibits ELIC by binding to a site overlapping with the POPG
site. DHA produces the opposite effect as POPG: it decreases peak
agonist response and increases desensitization12. Thus, it appears that
competition by different lipids (i.e., anionic phospholipids and fatty
acids) for this site modulates the relative stability of open-channel and
non-conducting conformations in ELIC.
While we propose a mechanism by which POPG stabilizes the openchannel conformation of ELIC, it is also possible that POPG and POPE
increase peak responses by promoting a coupled receptor. Previous
studies in the nAchR showed that in the absence of anionic phospholipids, the receptor adopts an uncoupled conformation11,48. However, the
structures of ELIC in POPC and 2:1:1 nanodiscs from the present study
show no differences that point to coupled and uncoupled conformations. Furthermore, fourier transform infrared spectroscopy
8
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Fig. 6 | Mutational analysis of the outer leaﬂet phospholipid binding site.
a ELIC5 CA structure showing POPG (yellow) at the outer leaﬂet site and residues
(dark blue) targeted by mutagenesis. b Tl+ ﬂux rates of mutants in response to
10 mM propylamine for no-exchange (red) and exchange (black, 25 mol% POPG in
the outer leaﬂet) conditions (n = 3). Source data are provided as a source data ﬁle.
c Weighted time constant of desensitization in response to 10 mM propylamine for

no-exchange (red) and exchange (black) conditions (n = 4 for WT, n = 3 for all
mutants). d Same as c showing peak rates of Tl+ ﬂux in response to 10 mM propylamine for no-exchange (red) and exchange (black) conditions (n = 4 for WT,
n = 3 for all mutants). All data are shown as mean ± s.e. for (n) independent
experiments. Statistical analysis was performed using a paired, two-sided T-test.

measurements indicate that ELIC does not adopt an uncoupled conformation with the same features as the nAchR in POPC membranes33.
Therefore, the current data do not support such a mechanism in ELIC.
Using asymmetric liposomes, we establish that POPG modulates
ELIC from the outer leaﬂet. The observed effect is unlikely to result
from ﬂipped inner leaﬂet POPG since the zeta potentials of asymmetric
liposome samples were not signiﬁcantly different from the 25% POPG
symmetric liposome control, deviating no more than 3 mV. This means
that a negligible amount of POPG could be present in the inner leaﬂet
with an estimated upper limit of ~3–4%44. In contrast, the effect of 25%
outer leaﬂet POPG, especially on desensitization, mimics what is
observed in 2:1:1 (25% POPG) symmetric liposomes supporting the
conclusion that POPG acts from the outer leaﬂet. It is also possible that
methyl-β-cyclodextrin could impact ﬂux rates by altering liposome size
or integrity; this seems unlikely given that methyl-β-cyclodextrin alone
did not signiﬁcantly impact ELIC-mediated ﬂux rates or produce a
noticeable loss of intra-liposomal ANTS. POPG modulation from the
outer leaﬂet agrees with the ﬁnding that PG is enriched in the outer

leaﬂet of gram negative bacteria membranes where ELIC is expressed49.
Interestingly, lipid densities have been observed in the structures of the
muscle nAchR, GluCl and the 5-HT3AR at this outer leaﬂet site19,23,28,50. In
addition, MD simulations of the glycine receptor showed statedependent binding of phospholipids between inactive and active
conformations at the top of M3 and M1—a site analogous to the POPG
binding site in ELIC51. Interestingly, R117 in the β6-β7 loop, which forms
an electrostatic interaction with the PG headgroup in the open-channel
structure, is conserved in GLIC and human pLGICs (Supplementary
Fig. 16). Thus, there is structural and computational evidence to suggest that a mechanism, similar to that proposed in the present study,
exists in human pLGICs. Anionic phospholipids are localized to the
inner leaﬂet of mammalian plasma membranes52; yet, it is thought that
some anionic phospholipids such as phosphatidylserine exist in the
outer leaﬂet of neuronal membranes and are dynamically regulated53. It
is possible that anionic phospholipids in the outer leaﬂet ﬁne-tune
agonist responses of mammalian pLGICs through this site, or that other
lipids more abundant in the outer leaﬂet act through this site.
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We report an open-channel structure of ELIC; all prior structures
of ELIC show a resting conformation14,26,32,54,55, with the exception of an
agonist-bound structure in POPC nanodiscs displaying partial
activation32. While we cannot exclude the possibility that the
ELIC5 structure is an artifact of mutations, the fact that this mutant has
a high steady-state open probability in the presence of agonist shows
excellent agreement between structure and function. The changes
transitioning from resting to activated conformations in ELIC are
generally conserved in other pLGICs, although our structures reveal
marked differences between non-conducting and open-channel conformations that are not appreciated to the same extent in other pLGICs
structures19,23,36,56,57. These include a signiﬁcant outward blooming of
the TM helices and expansion of the ECD β-sheets (β1-β6), indicating
that the transition from pre-active to open involves global conformational changes spanning the ECD and TMD. Such an observation is
consistent with a model that long-range global structural rearrangements underlie the transitions between functional states in pLGICs58.

Methods
Protein mutagenesis, expression, and puriﬁcation
The pET-26-MBP-ELIC was provided by Raimund Dutzler (Addgene
plasmid # 39239) and was used for the generation of both WT and
mutant ELIC. Site-directed mutagenesis was conducted using the
Quikchange method and subsequently conﬁrmed by Sanger sequencing (Genewiz). WT and mutant ELIC were expressed as previously
reported15,54 in OverExpress C43 (DE3) E. Coli (Lucigen). Terriﬁc Broth
(Sigma) was used to grow cultures which were induced with 0.1 mM
IPTG for ~16 h at 18 °C. The cells were pelleted, resuspended in Buffer A
(20 mM Tris pH 7.5, 100 mM NaCl) with complete EDTA-free protease
inhibitor (Roche), and lysed using an Avestin C5 emulsiﬁer at
~15,000 psi. Membranes were pelleted by ultracentrifugation, resuspended in Buffer A, solubilized with 1% DDM (Anatrace), and incubated
with amylose resin (New England Biolabs) for 2 h. The amylose resin
was washed with 20 bed volumes of Buffer A containing 0.02% DDM
and 0.05 mM TCEP (ThermoFisher Scientiﬁc), and eluted with 40 mM
maltose (Sigma). The eluted protein was digested with HRV-3C protease (ThermoFisher Scientiﬁc) (10 units per mg ELIC) overnight at 4 °C
then puriﬁed over a Sephadex 200 Increase 10/300 (GE Healthcare Life
Sciences) size exclusion column in Buffer A with 0.02% DDM.

Nanodisc reconstitution
Phospholipids (POPC, POPE, POPG) (Avanti Polar Lipid) were used as
received or combined to the desired ratio in chloroform, then dried
under a stream of nitrogen and placed in a vacuum desiccator overnight. The lipids were then rehydrated in Buffer A to a concentration of
7.5 mg/ml (~10 mM), sonicated for 5–10 min, and subjected to 5-10
freeze-thaw cycles using liquid nitrogen and a 37 °C heat block, and
ﬁnally extruded with a 400 nm ﬁlter 40× (Avanti Polar Lipids). Samples
were prepared using a 1:2:200 ratio of ELIC:MSP1E3D1:phospholipid.
300 µl samples were prepared by combining 74 µL Buffer A, 30 µL of
~10 mM liposomes, and 70 µL of 1% DDM in Buffer A yielding a 0.23%
DDM solution which was incubated at RT for 3 h. Next, 93 µL of
3 mg/mL (~16 µM) ELIC, or ELIC mutant, was added with 33 µL
of MSP1E3D1 at 3 mg/mL, then incubated at RT for 1.5 h. MSP1E3D1 was
expressed and puriﬁed according to previous reports, without removal
of the His-tag59. The pMSP1E3D1 plasmid was a gift from Stephen Sligar
(Addgene plasmid # 20066). Following incubation, the samples were
cooled on ice for 10 min followed by the addition of 80 mg Bio-beads
SM-2 Resin (Bio-Rad), then rotated at 4 °C overnight. The nanodisc
solution was puriﬁed on a Sephadex 200 Increase 10/300 column
using 10 mM HEPES with 100 mM NaCl at pH 7.5.

Cryo-EM sample preparation and imaging
3.0 µl of puriﬁed ELIC nanodiscs at an approximately concentration of
1.2 mg/ml were pipetted onto Quantifoil R2/2 copper grids post
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plasma cleaning in an H2/O2 plasma for 60 s (Solaris 950. Gatan).
Agonist bound samples were prepared by combining the puriﬁed
channels with cysteamine to a ﬁnal agonist concentration of 10 mM.
Post application of the sample, the grid was blotted for 2 s at ~100%
humidity and vitriﬁed via plunge freezing into a solution of liquid
ethane using a Vitrobot Mark IV (ThermoFisher Scientiﬁc). Post vitriﬁcation, grids were mounted in Autogrid holders and transferred to a
Titan Krios 300 kV Cryo-EM (ThermoFisher Scientiﬁc). Datasets were
collected in an automated fashion with the EPU acquisition software
(EPU 2.9.0.1519) using a Gatan K2 Summit camera mounted on a GIF
BioQuantum 968 energy ﬁlter (Gatan). Movies were collected in
counting mode with a nominal pixel size of 1.1 Å with the GIF set to a slit
width of 20 eV operating in zero-loss mode. Dose fractionated movies
were acquired over a defocus range of −1 to −2.5 µm. Each movie
consisted of 40 individual frames with a per-frame exposure time of
200 ms, resulting in a dose of 66 electrons per Å2.
For cryo-EM of liposomes, 3.0 µl of puriﬁed liposomes (POPC or
2:1:1) at 5 mg ml−1 were pipetted onto Lacey carbon grids which were
glow discharged for 12 seconds at 15 mA using a Gloqube (EMS). Post
application of the sample, each grid was blotted for 2 seconds at ~100%
humidity and vitriﬁed via plunge freezing into a solution of liquid
ethane using a Vitrobot Mark IV operating at 22 °C (ThermoFisher
Scientiﬁc). Post vitriﬁcation, grids were mounted in AutoGrid holders
and transferred to a Glacios 200 kV Cryo-EM (ThermoFisher Scientiﬁc).
Datasets were collected in an automated fashion with the EPU acquisition software using a Thermo Fisher Scientiﬁc Falcon 4 (ThermoFisher Scientiﬁc). Micrographs were collected with a nominal pixel size
of 1.9 Å. For cryo-EM images of liposome samples, liposome diameter
was manually determined in ImageJ using the polygon selection tool.

Single particle analysis and model building
Raw movies were motion corrected and subjected to dose weighting
with MotionCor260. Motion corrected and dose weighted images were
subject to contrast transfer function (CTF) determination using GCTF
v1.0661. After CTF determination, low-quality micrographs were
manually discarded. For each dataset ~2500 particles were hand
selected for 2D class averaging from which templates were derived for
automated particle picking in RELION3.162. Particles were extracted
and subjected to multiple rounds of 2D and 3D classiﬁcation. For WT
ELIC CA in POPC nanodiscs, an initial 3D model was generated using a
40 Å-low-pass ﬁltered map of PBD 2YN6 [https://www.wwpdb.org/
pdb?id=pdb_00002yn6] and used for subsequent 3D classiﬁcations.
The other ﬁve datasets utilized a 40 Å-low-pass ﬁltered map from the
WT ELIC CA POPC dataset as an initial model. 3D classiﬁcation was
performed using C5 symmetry and no signiﬁcant differences were
identiﬁed among good classes. The best 3D reﬁned maps were then
masked and post-processed, followed by CTF reﬁnement and Bayesian
polishing. To compare the strength of the phospholipid density
between WT apo, WT CA and ELIC5 CA structures, each structure was
low-pass ﬁltered to 3.5 Å63. Next, the lipid density was visualized in
PyMOL 2.5.2 by adjusting the σ-level to 3.064. Other images of the
structures were generated using UCSF Chimera 1.1465.
An initial model of the WT CA 2:1:1 structure was generated by
docking an ELIC crystal structure (PDB 2YN6 [https://www.wwpdb.org/
pdb?id=pdb_00002yn6]) into the cryo-EM density map using UCSF
Chimera and then performing real space reﬁnement using PHENIX
1.19.2-415865,66. The remaining structure was manually built de novo
into the density map using COOT 0.9.8.1 prior to iterative real space
reﬁnement using PHENIX67. Prior to ﬁnalizing the model manual
adjustments were made using COOT and veriﬁed in PHENIX. The other
structures were built by docking the WT CA 2:1:1 structure into each
density map and following the same procedure above. A nonproteinaceous density was observed in the agonist binding site of
structures obtained in the presence of 10 mM cysteamine. Cysteamine
was placed in this density in an orientation previously shown to be
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favorable by MD simulations32. Resolved phospholipid-like densities (a
head group and two branching tails) were ﬁt with POPG for those
structures determined in 2:1:1 nanodiscs and POPC for those structures
determined in POPC nanodiscs. Phospholipids were generated using
ELBOW in PHENIX.

Giant liposome excised patch-clamp recordings of ELIC
Giant liposome formation and excised patch-clamp recordings of ELIC
were performed as previously described12,13. 0.5 mg of WT ELIC, ELIC3
or ELIC5 were reconstituted in 5 mg of 2:1:1 POPC:POPE:POPG liposomes, using DDM destabilization and biobeads. 10 mM MOPS pH 7
and 150 mM NaCl (MOPS buffer) was used throughout. Proteoliposomes were pelleted and resuspended in ~80 µl, and frozen in 10 µl
aliquots. Giant liposomes were formed by dehydrating 10 µl of proteoliposomes on a glass coverslip in a vacuum desiccator for ~20 min
followed by rehydration with 100 µl of MOPS buffer overnight at 4 °C
and 2 hr at RT the following day. The giant liposomes were resuspended by pipetting and applied to a recording chamber. The liposomes were allowed to settle for 15 min, after which free liposomes and
debris were removed by exchanging the bath solution. Bath and pipette solutions contained MOPS buffer and 0.5 mM BaCl2 (Sigma). The
addition of BaCl2 was necessary to facilitate the formation of giga-ohm
seals. However, this concentration of BaCl2 also leads to a right-shift in
the agonist dose-response curve, such that the EC50 for cysteamine
(Sigma) is ~4-5 mM instead of 1-2 mM. Of note, no BaCl2 was used in the
ﬂuorescence stopped-ﬂow liposomal ﬂux assay, such that the dose
response curve for propylamine (Sigma) in 2:1:1 liposomes yielded an
expected EC50 of ~2 mM. All recordings were voltage-clamped at
−60 mV and data collected at 5 kHz using an Axopatch 200B ampliﬁer
and Digidata 1440 A (Molecular Devices). Rapid application or washout
of agonist were performed using a three-barreled ﬂowpipe mounted to
and controlled by a SF-77B fast perfusion system (Warner Instrument
Corporation). The 10–90% exchange time was previously determined
to be ~2 ms in this system using a liquid junction current across an
open pipette, such that solution exchanges are sufﬁciently fast to
capture ELIC activation and deactivation kinetics. Deactivation time
courses were ﬁt with a single exponential while the time course of
desensitization was ﬁt with a double exponential. Weighted time
constants were calculated using Eq. 1:
Weighted Tau =

ð A1 × τ1Þ + ðA2 × τ2Þ
A1 + A2

ð1Þ

where A1 and A2 are the amplitudes of the ﬁrst and second exponential
components. The data were collected and analyzed using
pClamp10.4 software.

Stopped-ﬂow ﬂuorescence recordings

The ﬂuorescence sequential-mixing stopped-ﬂow liposomal ﬂux
measurements were carried using an SX20 stopped-ﬂow spectroﬂuorometer (Applied Photophysics) and Pro-Data SX software13,30.
7.5 mg of the respective lipid mixture (POPC, 1:1 POPC: POPE, 1:1
POPC:POPG, 3:1 POPC:POPE, 3:1 POPC:POPG, 2:1:1 POPC:POPE:POPG)
was dried in a glass vial to a thin ﬁlm under a constant stream of N2.
The lipids were then further dried under vacuum in a desiccator
overnight. The following day the lipids were hydrated in 500 µl of
reconstitution buffer (100 mM NaNO3, 10 mM HEPES, pH 7) (Buffer
R), 250 µl of 75 mM 8-Aminonaphthalene-1,3,6-Trisulfonic Acid
(ANTS, ThermoFisher Scientiﬁc) in buffer R, and doped with ~18 mg
of CHAPS (Anatrace). The mixture was vortexed and then sonicated
with heat until completely solubilized. Following the sonication, the
solution was brought to RT then 3.5 µl of 6.7 mg/ml ELIC in Buffer A
with 0.02% DDM was added (3 µg per mg of lipid). This combined
solution was incubated at RT for 30 min, followed by the addition of
1 ml of 1:1 v/v SM-2 BioBeads in Buffer R and an additional 250 µl of
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75 mM ANTS in Buffer R. This mixture was incubated at RT for 2.5 hr
with gentle mixing. The liposome suspension was then extruded with
an Avanti mini-extruder and 0.1 µm membrane (30×). The extruded
liposomes were stored at 13 °C overnight with gentle rotation. The
next day, the liposomes were diluted to 2.5 mL using assay buffer
(140 mM NaNO3, 10 mM HEPES, pH 7) (Stopped-ﬂow Buffer A), loaded into a PD-10 desalting column (Cytiva), eluted with 3 mL of
Stopped-ﬂow Buffer A and subsequently diluted 5-fold with Stoppedﬂow Buffer A.
Using propylamine as the agonist, the assay and analysis was
carried out as previously described13,30. ELIC-containing liposomes
were ﬁrst mixed 1:1 with Buffer A containing 2× the concentration of
propylamine. After a variable delay of 10 ms to 25 s, the sample was
then mixed 1:1 with a quenching buffer (90 mM NaNO3, 50 mM TlNO3,
10 mM HEPES, pH 7), and ANTS ﬂuorescence (ex. 360 nm, ﬂuorescence
above 420 nm) was recorded for 1 s. For each delay time, 5 repeat
measurements were obtained. The data were collected using Applied
Photophysics Pro-Data SX software. The ﬂuorescence quenching traces were ﬁt to a stretched exponential (Eq. 2a) and the rate of Tl+ inﬂux
was determined at 2 ms (Eq. 2b).

  t β
F t = F 1 + F 0  F 1  e ðτÞ

kt =

  

β
2ms ðβ1Þ

τ
τ

ð2aÞ

ð2bÞ

where Ft, F∞, F0 are the ﬂuorescence at time t, ﬁnal ﬂuorescence and
initial ﬂuorescence. τ is the time constant, β the stretched exponential
factor, and kt the calculated rate of Tl+ inﬂux at 2 ms. The time course
of desensitization was also ﬁt to a double exponential and a weighted
time constant was calculated as was done for the patch-clamp data
using Origin 2019b. All replicates were taken from independent
samples.

Tryptophan stopped-ﬂow ﬂuorescence measurements

To measure the tryptophan (Trp) ﬂuorescence emission of ELIC, WT or
W206F ELIC was diluted to 3 ml (0.02 mg/ml) and an emission spectrum was collected in a quartz ﬂuorescence cell using a Fluoromax Plus
Spectroﬂuorometer (Horiba Scientiﬁc). Excitation was set at 295 nm
and an emission spectrum was collected from 320 to 380 nm. Trp
ﬂuorescence measurements with rapid mixing of agonist was carried
out using the SX20 stopped-ﬂow spectroﬂuorometer, outﬁtted with a
295 nm LED excitation source. Puriﬁed ELIC was diluted to 0.1 mg/ml in
Trp Stopped-ﬂow Buffer A (10 mM Tris pH 7.5, 100 mM NaCl, 0.05%
DDM). A single mixing experiment was performed by mixing ELIC with
equal volumes of Buffer A + propylamine. Propylamine was prepared
at varying concentrations at 2x the ﬁnal concentration. The instrument
dead time was ~1 ms, enabling capture of most of the time course of
change in Trp ﬂuorescence. The time course of decrease in Trp
ﬂuorescence after rapid mixing with propylamine was ﬁt to a single
exponential to obtain a time constant for the rate of decrease and a
measure of the extent of decrease. All replicates were taken from
distinct samples.

Asymmetric liposome formation and analysis
Acceptor liposomes were prepared as described in the Stopped-ﬂow
ﬂuorescence recordings section until completion of the extrusion step.
The preparation was scaled up 2x to produce samples for the noexchange and exchange conditions. After extrusion and storage of the
liposomes overnight at 13 °C, the double liposome preparation was
split into two equal volume aliquots of ~1.5 ml. Using the excel
spreadsheet provided by Markones et al.44, donor POPG and methyl-βcyclodextrin (MβCD, Sigma) concentrations and volumes were calculated to produce an outer leaﬂet POPG content of 25 mol% in the
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liposomes. The calculations assumed a ~6.66 mM lipid concentration
and 1.5 mL volume of the acceptor liposome solution44. A MβCD-POPG
(50% saturation of MβCD by POPG) solution was formed by combining
224 µL 7.5 mM POPG in Stopped-ﬂow Buffer A, 650 µl 300 mM MβCD in
Stopped-ﬂow Buffer A, and 126 µL Stopped-ﬂow Buffer A, which was
then mixed at 50 °C and 1000 RPM for 20 min using an Eppendorf
thermomixer. In parallel, an analogous POPG-free solution was generated and treated in the same manner except 224 µL of Stopped-ﬂow
Buffer A was used in lieu of the POPG solution. Next, the solutions and
thermomixer were cooled to 28 °C. Following cooling, the 1.5 ml of
acceptor liposomes were combined with the respective 1 ml MβCD
solution, either containing POPG (exchange condition) or no POPG (no
exchange condition). These samples were mixed at 28 °C and 400 RPM
for 20 min using a thermomixer to complete the transfer of POPG to
the liposomes. After mixing, the ~2.5 ml of each respective sample were
loaded on a PD-10 column and eluted with 3 mL Stopped-ﬂow Buffer A.
The ﬂuorescence stopped-ﬂow liposomal ﬂux assay and analysis of the
data were carried out on both the no exchange and exchange samples
in sequence as described in Stopped-ﬂow ﬂuorescence recordings13. All
replicates were taken from distinct samples.

Zeta potential measurements
The zeta potential (ζ) is the electrical potential on the surface of
nanoparticles (e.g., liposomes), speciﬁcally at the slipping plane, which
is between a diffuse layer of solvent and ions interacting with the
particle surface and the mobile bulk solvent. For liposomes, this
electrical potential is determined by the overall charge on the outer
leaﬂet of the lipid membrane, and can be used to assess introduction of
POPG to the outer leaﬂet of liposomes44. ζ measurements were made
on a Malvern Zetasizer Nano-ZS ZEN 3600 (Zetasizer nano software
v3.30) using a ﬂow-through high concentration zeta potential cell
(HCC) following a previously described method44,45. The instrument
was equilibrated for 20 min at 28 °C prior to analysis. Instrument settings included: temperature 28°, 90 s incubation time, 10-100 runs,
and the dispersant settings were set as water for all samples. ζ was
measured in triplicate for each sample. Prior to each measurement the
HCC was ﬂushed with copious volumes of preheated ddH2O water and
dried under a ﬂow of N2. The sample was prepared using liposomes
immediately after desalting on the PD-10 column, and diluting 100 µl of
liposomes with 100 mM HEPES at pH 7 to a ﬁnal volume of 1 ml (ﬁnal
MβCD ~ 4.3 mM). The sample was then loaded into a 1 ml syringe and
the liposome suspension was driven into the cell until all air was displaced. Upon each subsequent measurement an additional ~250 µl was
pushed through the cell to displace old solution. After use, the HCC
was disassembled and cleaned with 1% Hellmanex II in ddH2O and
dried44.

Molecular dynamics simulation
Initial protein–lipid complexes were modeled directly from cryo-EM
maps with lipid densities. The ﬁrst 11 protein residues were not modeled. The lipid densities were modeled using POPC, POPE, or POPG.
These initial structures were then inserted into POPC membranes and
equilibrated using default procedures from CHARMM-GUI68. All
simulations were carried out using the CHARMM36m forceﬁeld69 with
cation-pi corrections70 Simulations were executed using NAMD 2.1471
in a semi-isotropic NPT ensemble tailored for membranes: a Langevin
piston barostat with a target temperature of 303.15 K and a target
pressure of 1 atmosphere with isotropic ﬂuctuations enforced in the
membrane plane. The piston period was increased to 200 steps (2 fs
time step) and the decay to 100; this reduced instabilities due to higher
frequency ﬂuctuations. Following the default relaxation scheme of
CHARMM-GUI68,72, systems were further relaxed for at least 20 more
nanoseconds to ensure equilibration and to determine the expected
deviation of the glycerol backbone due to thermal ﬂuctuations around
the modeled binding pose. As described below, these simulations are
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essential for parameterizing the Distance-to-Bound-Conﬁguration
(DBC) coordinate used in the SAFEP approach, but are not intended
to thoroughly sample the full range of conﬁgurations available to the
lipid or protein. Membrane-only systems were similarly created and
equilibrated.

Streamlined alchemical free energy perturbation (SAFEP)
simulations
We performed binding free energy estimation using the molecular
dynamics simulation settings previously described, with alchemical
calculations using the SAFEP framework29. SAFEP is a simpliﬁed
approach to calculating free energies of ligand binding using free
energy perturbation (FEP). A primary challenge in FEP calculations is
preventing spontaneous unbinding during simulation which would
adversely impact the sampling efﬁciency. In the SAFEP framework29,
the bound state is deﬁned as a region of the conﬁguration space for the
ligand (RMSD) relative to the bound pose in the protein frame of
reference (a.k.a. the “Distance-to-Bound-Conﬁguration” or DBC).
Interleaved-double wide sampling (IDWS) improves efﬁciency of any
FEP by sampling in both the forward and backward lambda directions
alternately (unlike traditional FEP in which each lambda value is
simulated twice; once with forward sampling and once with backward
sampling).
As in other relative FEP methods, the zero-sum nature of thermodynamic cycles is exploited to calculate interesting relative free
energy differences from more computationally accessible data. In this
case, the alchemical free energies of transformation calculated by
SAFEP (summarized in Table 1) can be combined to calculate relative
free energies of replacement of one lipid with another:
b
a
a!b
 ΔGa!b
ΔΔGa!b
Bulk!M = ΔGBulk!M  ΔGBulk!M = ΔGM
Bulk

ð3Þ

where a and b are generic lipid species, M is a protein conformation,
is the free energy cost of transforming a lipid of species a to
ΔGa!b
M
species b bound to M, ΔGbBulk!M is the free energy cost of transferring a
lipid of species b from the bulk to a protein in state M, and ΔΔGa!b
Bulk!M
is the relative free energy of exchanging a bound lipid of species a with
a lipid of species b from the bulk.
Free energies of transformation of bound ligands ðΔGa!b
M Þ were
calculated for each of two conformations (WT and ELIC5) and each of
three a-b pairs (POPC vs POPE, POPG vs POPE, POPC vs POPG). In this
case, the bound pose could be deﬁned using a relaxed conformation of
the initial protein-lipid complex. The DBC only included the glycerol
atoms of the lipid since inclusion of the more ﬂexible acyl chains and
headgroups would require a much looser restraint, thus reducing the
sampling beneﬁts.
Following equilibration of the membrane-embedded proteins, the
bound lipid was replaced by one of three hybrid (or “dual”) topologies:
alchemical lipids which share acyl chains and glycerol cores, but bear
two separate phospholipid headgroups. Protein-lipid FEP calculations
were carried out with half ﬂat-bottom DBC restraints on the bound
lipid to prevent unbinding. The upper wall was placed near the 95th
percentile of the unbiased simulation of POPC bound to ELIC5 (the
most weakly bound protein-lipid complex), which corresponded to 6 Å
(Supplementary Fig. 13). 120 lambda windows of 3 ns per window were
run in an embarrassingly parallel arrangement. The systems were
equilibrated at each lambda value for at least one nanosecond prior to
collection of FEP data. All SAFEP calculations used IDWS for simultaneous calculation of the reverse transformation. Due to the computational cost of these simulations, a single replica was run for each lipid
transformation for each conformation (6 individual calculations total).
Membrane-only simulations used to calculate ΔGa!b
Bulk lacked DBC
restraints but required two modiﬁcations to prevent lipid ﬂipping
during FEP. The electrostatic scaling was started at lambda = 0.25
instead of 0.5; this setting prevented complete discharging of the lipid.
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Forty linearly spaced 1.4 ns FEP windows were used, with 0.5 ns of
equilibration prior to collection of FEP data. This modiﬁcation was not
sufﬁcient to prevent lipid ﬂipping for some transformations involving
POPE and POPG (Supplementary Figs. 17 and 18), and in these cases a
ﬂat-bottom harmonic restraint was placed between the central carbon
on the FEP lipid and a lipid in the opposite leaﬂet (lower bound 28.5 Å;
upper bound 41.5 Å; force constant 4.0 kcal/mol/Å2). Five replicas were
run for each lipid comparison in each membrane composition. Replicas
were generated by selecting a different lipid for each calculation.

SAFEP analysis and convergence-testing
The output from the FEP calculations was used to estimate the difference in free energy between the two end states using an accumulated Bennett’s Acceptance Ratio estimator (BAR) as implemented in
PyMBAR73 using the alchemlyb interface74, and custom scripts. Decorrelated samples were obtained using subsampling utilities available
in those libraries. Replicate data were aggregated for ﬁnal free energy
estimations. Errors were estimated by using the BAR estimator as
implemented in PyMBAR in the case of the protein FEP calculations
and by the standard error of the mean of replicas in the case of the
membrane FEP calculations. All analysis scripts are available on
GitHub75.
We considered convergence of the calculations through several
metrics. The cumulative change in free energy with respect to λ are
shown in Supplementary Figs. 17 and 21. We further tested convergence by comparing the cumulative ΔG values that resulted from
using the ﬁrst vs second half of the raw data, for each replica (Supplementary Figs. 18 and 22), and required that these values be within
~1 kcal/mol of each other. Finally, internal hysteresis was assessed by
calculating the difference δ λ between the forward and backward
exponential free energy estimates per window. Well-converged calculations are expected to have only small differences between forward
and backward calculations (Supplementary Figs. 19 and 23) that are
randomly distributed with respect to lambda (Supplementary Figs. 20
and 24). We used approximately minimal lambda schedules to ensure
convergence thus deﬁned; shorter, fewer windows were found to yield
inadequate sampling of the ensembles.

Pharmacological and allosteric predictions
The relative free energies of replacement calculated above (Eq. 4a,
Table 1) can then be converted to relative binding constants:
K ab
M =

K bM
K aM

= exp 

ΔΔGa!b
Bulk!M

!
ð4aÞ

RT

Where K aM is the absolute binding constant of lipid a to state M, and Kab
M
is the relative binding constant of lipid b relative to that of lipid a. For
example, the state-dependent binding constant for POPG binding to
the ELIC5 conformation (relative to POPC) is:
K CG
ELIC5 =

K PG
ELIC5
K PC
ELIC5

= exp 

PC!PG
ΔΔGBulk!ELIC5
RT

!
ð4bÞ

The above can be extended to predictions of allosteric modulation if we make the following assumptions:
1. ELIC has at least two distinct conformations, which we denote
ELIC5 and WT.
2. A maximum of three lipid species are present: POPE, POPC, and
POPG. The sum of mole fractions of the three lipids is 1:
xPOPC + xPOPE + xPOPG = 1
3. The allosteric effects of each binding site are independent of the
other binding sites.
4. The probability of a site being unoccupied is negligible (i.e., when
a lipid leaves the binding site it is rapidly replaced by another).
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Under these assumptions, the probability paocc,M of a site in conformation M to be occupied by a lipid of species a is

1
xb
ac x c
+
K
,
paocc,M = 1 + K ab
M
M
xa
xa

ð5aÞ

For example, the fraction of sites occupied by POPC in the ELIC5
conformation is


x PE 1
CG x PG
CE
=
1
+
K
+
K
,
pPC
occ,ELIC5
ELIC5
ELIC5
x PC
x PG

ð5bÞ

The relative probability of observing the protein in each of the two
conformations, as a function of lipid composition, is derived below.
First, the law of mass action for a lipid binding to a given conformation
is given by the product of the total amount of protein in that state, the
equilibrium constant of binding, and the mole fraction of the lipid in
the membrane. For example:
½ELIC5POPC  = ½ELIC5+ K POPC
ELIC5 x PC ,

ð6Þ

where ½ELIC5POPC  and ½ELIC5+  are the concentrations of ELIC in the
ELIC5 state, with bound POPC and without a bound lipid, respectively.
The probability ratio of observing ELIC in the ELIC5 conformation vs
the WT conformation ppELIC5 is then:
WT

+

POPE
POPG
pELIC5 ½ELIC5  1 + K POPC
ELIC5 x PC + K ELIC5 x PE + K ELIC5 x PG
=
:

+
POPC
POPE
POPG
pWT
½WT  1 + K WT x PC + K WT x PE + K WT x PG

ð7aÞ

We assume that the fraction of receptors with unoccupied sites is
negligible, and switch to POPC-relative binding constants to obtain:
CG
pELIC5 pPOPC
x + K CE
ELIC5 x PE + K ELIC5 x PG
= ELIC5
 PC
,
POPC
CE
pWT
pWT
x PC + K WT x PE + K CG
WT x PG

ð7bÞ

This expression yields the ratio between the overall population of
both conformations as the ratio obtained in pure POPC, multiplied by
the modulation factor due to the presence of POPE and POPG lipids.
We separate the latter contribution and take its logarithm, yielding the
quantity plotted in Fig. 5c:


CG
p
pELIC5
pWT
x + K CE
ELIC5 x PE + K ELIC5 x PG
Δ log ELIC5  log POPC
 log POPC
= log PC
:
CE
pWT
pELIC5
pWT
x PC + K WT x PE + K CG
WT x PG

ð8Þ

Statistical Information
Statistical analysis was performed as indicated in the ﬁgure legends.
For the data in Fig. 1d, e and Supplementary Fig. 2, a one-way ANOVA
with a post-hoc Tukey’s test was performed. For the data in Figs. 4 and
6, the no exchange and exchange samples were compared using a
paired, two-sided T-test. For the data in Supplementary Fig. 6c–e, WT
and ELIC3 were compared using an unpaired, two-sided T-test. All data
are reported as mean ± SEM. No sample size calculation as made.

Reporting summary
Further information on research design is available in the Nature
Portfolio Reporting Summary linked to this article.

Data availability
The data supporting the ﬁndings of this study are available within the
paper and supplementary information ﬁles and available from the
corresponding author upon request. The cryo-EM maps have been
deposited in the Electron Microscopy Data Bank (EMDB) under
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accession codes EMD-27216 (WT CA POPC), EMD-27215 (WT Apo
POPC), EMD-27218 (WT CA 2:1:1), EMD-27217 (WT Apo 2:1:1), EMD-27219
(ELIC3 CA 2:1:1), EMD-27220 (ELIC5 CA 2:1:1). The structural coordinates
have been deposited in the RCSB Protein Data Bank (PDB) under the
accession codes 8D64 (WT CA POPC), 8D63 (WT Apo POPC), 8D66 (WT
CA 2:1:1), 8D65 (WT Apo 2:1:1), 8D67 (ELIC3 CA 2:1:1), 8D68 (ELIC5 CA
2:1:1). Initial model building of the ELIC CA 2:1:1 structure used the ELIC
crystal structure, PDB 2YN6. Source data are provided with this paper.

Code availability
FEP data and analysis scripts are available at https://github.com/
BranniganLab/ELIC-phospholipid-identiﬁcation
(https://doi.org/10.
5281/zenodo.7264978).
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